RA Capital Healthcare Fund LP's Form 4 filing
AN2 Therapeutics, Inc. (ANTX) · filed Aug 13, 2024
- Accession no.
- 0001415889-24-021199
- Filed
- Aug 13, 2024, 5:03 PM ET
- Trade date
- Aug 9, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $3.81M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| RA Capital Healthcare Fund LPCIK 0001315082 | 10% Owner |
| Ra Capital Management, L.P.CIK 0001346824 | 10% Owner |
| Kolchinsky PeterCIK 0001384859 | 10% Owner |
| Shah Rajeev M.CIK 0001619841 | 10% Owner |
| RA Capital Nexus Fund II, L.P.CIK 0001825376 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 9, 2024 | Common Stock | SSaleDisposed | −3,410,335 | $1.08 | −$3,683,161.8 | 1,725,348 | Indirect | |
| Aug 9, 2024 | Common Stock | SSaleDisposed | −114,759 | $1.08 | −$123,939.72 | 300,853 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.